Nephros Inc (NEPH) stock
NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3026% below fair value
$3.05−0.26 (-7.85%)
Close on Nov 13, 2026Market cap $33.12MP/E 16.9Yield –
Nephros total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Nephros's total debt was $482.00K at Dec 31, 2020. For fiscal 2020 it was $482.00K, down 3.6% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $482.00K | -3.6% |
| FY2010 | Dec 31, 2010 | $500.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2020 | Dec 31, 2020 | $482.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $141.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $201.00K | – |
See a number that looks wrong?